...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New Zenith poster
Reply New Message
Back To Forum List View
New Zenith poster
6
GeorgeParros
Dec 10, 2020 04:13PM

Phase 2 portion of the trial, ZEN-3694 + Talazoparib (TALB), is ongoing.

What's it going to take to IPO Zenith, once and for all?

 

Koo

4 Recommendations
Re: New Zenith poster
4
Telepanel
Dec 11, 2020 11:07AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply